Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Intracranial Arterial Dolichoectasia in Patients with Ischemic Stroke: Preliminary Results From the IDEAS Study
Cerebrovascular Disease and Interventional Neurology
P14 - Poster Session 14 (8:00 AM-9:00 AM)
4-021
Intracranial Arterial Dolichoectasia (IADE) denotes the abnormal dilation, elongation and tortuosity of cerebral arteries. Despite the known pathogenic linkage between IADE and ischemic stroke, IADE is often overlooked as a cause of brain infarction. The study aim is to determine the frequency of IADE in acute ischemic stroke employing an objective definition pertinent for all major intracranial vessels.
NA

Consecutive patients admitted with acute ischemic stroke to a single tertiary-care hospital were analyzed. Utilizing semi-automatic vessel segmentation (TeraRecon; Foster City, CA, USA), IADE was defined as at least one major intracranial vessel with abnormal diameter, length, and/or tortuosity index (value ≥2 SD from the population mean). Symptomatic IADE was considered when the infarct was located in the territory of an affected vessel in the absence of an alternative pathogenic explanation.

Among 150 subjects screened, 142 (68 ±13.5 years; 50% female) had vessel imaging done during admission and were included in the analysis. IADE was detected in 58 (40.8%) individuals. A single vessel was affected in 21%, two vessels in 11.3%, and ≥3 vessels in 8.4%. Demographic profile and prevalence of vascular risk factors were similar between stroke patients with and without IADE. IADE was present in 45.5% of patients with large-artery atherosclerosis, 33.3% with small vessel disease, 25% with cardioembolic stroke, and 60.5% with undetermined etiology. Among 110 patients who underwent MRI-DWI verification of infarct location, 17 (15.5%) had IADE affecting the culprit vessel and eight (7.3%) were considered to have symptomatic IADE.

IADE is a common finding in patients with ischemic stroke, mainly in patients with large-artery atherosclerosis and cryptogenic mechanisms. One-fifth of strokes attributed to undetermined mechanism may be directly related to dilative arteriopathy.
Authors/Disclosures
Victor J. Del Brutto, MD
PRESENTER
The institution of Dr. Del Brutto has received research support from Florida Health Department. The institution of Dr. Del Brutto has received research support from american heart association.
No disclosure on file
Viviana Jimenez, MD Dr. Jimenez has nothing to disclose.
Ralph L. Sacco, MD, MS, FAHA Dr. Sacco has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Sacco has received research support from NIH, NINDS, NCATS, NIMHD. The institution of Dr. Sacco has received research support from FL Department of Health. Dr. Sacco has received research support from University of Washington, Seattle. Dr. Sacco has received publishing royalties from a publication relating to health care.
Tatjana Rundek, MD, PhD The institution of Dr. Rundek has received research support from NIH.
Jose G. Romano, MD, FÂé¶¹´«Ã½Ó³»­ (University of Miami, Miller School of Medicine) Dr. Romano has stock in Vycor Medical/NovaVision. The institution of Dr. Romano has received research support from NIH/NINDS. The institution of Dr. Romano has received research support from NIH/NHLBI.